Literature DB >> 26963364

Moderators of Remission in Patients With Late-Life Depression: Where Do We Go Next?

Warren D Taylor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26963364      PMCID： PMC5054742          DOI： 10.1001/jamapsychiatry.2015.3458

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  7 in total

1.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.

Authors:  Eric J Lenze; Benoit H Mulsant; Daniel M Blumberger; Jordan F Karp; John W Newcomer; Stewart J Anderson; Mary Amanda Dew; Meryl A Butters; Jacqueline A Stack; Amy E Begley; Charles F Reynolds
Journal:  Lancet       Date:  2015-09-27       Impact factor: 79.321

Review 2.  The vascular depression hypothesis: mechanisms linking vascular disease with depression.

Authors:  W D Taylor; H J Aizenstein; G S Alexopoulos
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

Review 3.  Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues.

Authors:  Lars Bäckman; Ulman Lindenberger; Shu-Chen Li; Lars Nyberg
Journal:  Neurosci Biobehav Rev       Date:  2009-12-21       Impact factor: 8.989

4.  Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.

Authors:  Shriya H Kaneriya; Gregg A Robbins-Welty; Stephen F Smagula; Jordan F Karp; Meryl A Butters; Eric J Lenze; Benoit H Mulsant; Daniel Blumberger; Stewart J Anderson; Mary Amanda Dew; Francis Lotrich; Howard J Aizenstein; Breno S Diniz; Charles F Reynolds
Journal:  JAMA Psychiatry       Date:  2016-04       Impact factor: 21.596

5.  Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.

Authors:  Helen Lavretsky; Michelle Reinlieb; Natalie St Cyr; Prabha Siddarth; Linda M Ercoli; Damla Senturk
Journal:  Am J Psychiatry       Date:  2015-02-13       Impact factor: 18.112

6.  Moderators of outcome in late-life depression: a patient-level meta-analysis.

Authors:  J Craig Nelson; Kevin L Delucchi; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

7.  Neuroplasticity-based computerized cognitive remediation for treatment-resistant geriatric depression.

Authors:  Sarah Shizuko Morimoto; Bruce E Wexler; Jiacheng Liu; Willie Hu; Joanna Seirup; George S Alexopoulos
Journal:  Nat Commun       Date:  2014-08-05       Impact factor: 14.919
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.